4//SEC Filing
KKR Associates HCSG L.P. 4
Accession 0001140361-19-019741
CIK 0001720725other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 6:19 PM ET
Size
15.6 KB
Accession
0001140361-19-019741
Insider Transaction Report
Form 4
KKR HCSG GP LLC
10% Owner
Transactions
- Purchase
Common Stock, par value $0.001 per share
2019-11-04$16.00/sh+155,000$2,480,000→ 1,039,622 total(indirect: See footnotes) - Conversion
Series B Convertible Preferred Stock
2019-11-04−884,622→ 0 total(indirect: See footnotes)→ Common Stock, par value $0.001 per share (884,622 underlying) - Conversion
Common Stock, par value $0.001 per share
2019-11-04+884,622→ 884,622 total(indirect: See footnotes)
KKR Associates HCSG L.P.
10% Owner
Transactions
- Conversion
Common Stock, par value $0.001 per share
2019-11-04+884,622→ 884,622 total(indirect: See footnotes) - Conversion
Series B Convertible Preferred Stock
2019-11-04−884,622→ 0 total(indirect: See footnotes)→ Common Stock, par value $0.001 per share (884,622 underlying) - Purchase
Common Stock, par value $0.001 per share
2019-11-04$16.00/sh+155,000$2,480,000→ 1,039,622 total(indirect: See footnotes)
Falcon Vision LLC
10% Owner
Transactions
- Purchase
Common Stock, par value $0.001 per share
2019-11-04$16.00/sh+155,000$2,480,000→ 1,039,622 total(indirect: See footnotes) - Conversion
Series B Convertible Preferred Stock
2019-11-04−884,622→ 0 total(indirect: See footnotes)→ Common Stock, par value $0.001 per share (884,622 underlying) - Conversion
Common Stock, par value $0.001 per share
2019-11-04+884,622→ 884,622 total(indirect: See footnotes)
Transactions
- Conversion
Common Stock, par value $0.001 per share
2019-11-04+884,622→ 884,622 total(indirect: See footnotes) - Purchase
Common Stock, par value $0.001 per share
2019-11-04$16.00/sh+155,000$2,480,000→ 1,039,622 total(indirect: See footnotes) - Conversion
Series B Convertible Preferred Stock
2019-11-04−884,622→ 0 total(indirect: See footnotes)→ Common Stock, par value $0.001 per share (884,622 underlying)
Footnotes (3)
- [F1]These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock, on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering.
- [F2]The securities reported herein are held by Falcon Vision LLC. KKR Health Care Strategic Growth Fund L.P., as the managing member of Falcon Vision LLC, KKR Associates HCSG L.P., as the general partner of KKR Health Care Strategic Growth Fund L.P., KKR HCSG GP LLC, as the general partner of KKR Associates HCSG L.P., KKR Fund Holdings L.P., as the sole member of KKR HCSG GP LLC, KKR Fund Holdings GP Limited, as a general partner of KKR Fund Holdings L.P., KKR Group Holdings Corp., as a general partner of KKR Fund Holdings L.P. and the sole shareholder of KKR Fund Holdings GP Limited, KKR & Co. Inc., as the sole shareholder of KKR Group Holdings Corp., KKR Management LLC, as the Class B common stockholder of KKR & Co. Inc., and Messrs. Henry R. Kravis and George R. Roberts, as the designated members of KKR Management LLC, may be deemed to be the beneficial owners having shared voting and investment power with respect to the shares described in this footnote.
- [F3]Each of Messrs. Kravis and Roberts disclaims beneficial ownership of the shares held by Falcon Vision LLC.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001792766
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 6:19 PM ET
- Size
- 15.6 KB